chitosan has been researched along with Ascites in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| El-Maraghy, SA; Motawi, TK; Nady, OM; Sabry, D; Senousy, MA | 1 |
| Deng, S; Deng, Y; Hu, Y; Huang, J; Jin, H; Liao, Z; Liu, Y; Lovell, JF; Meng, J; Tian, Y; Tuo, Z; Yang, K; Yang, X; Zhou, Z | 1 |
| Allen, C; Cho, J; Grant, J; Ho, E; Lim Soo, P; Piquette-Miller, M | 1 |
3 other study(ies) available for chitosan and Ascites
| Article | Year |
|---|---|
Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.
Topics: Animals; Ascites; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Chitosan; Cromolyn Sodium; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Genes, p16; Heterografts; Humans; Mice; Nanoparticles; RNA, Neoplasm | 2022 |
Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma.
Topics: Ascites; Carcinoma, Hepatocellular; Chitosan; Dextrans; Ferroptosis; Humans; Hydrogels; Immunotherapy; Liver Neoplasms; Sulfasalazine | 2023 |
Drug release mechanism of paclitaxel from a chitosan-lipid implant system: effect of swelling, degradation and morphology.
Topics: Animals; Ascites; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Drug Implants; Female; Humans; Lipids; Mice; Mice, Inbred BALB C; Ovarian Neoplasms; Paclitaxel; Prostheses and Implants | 2008 |